Risk factors of multidrug-resistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a Medical Intensive Care Unit of University Hospital in Thailand

Journal of Infection and Chemotherapy

Volumn 21, Issue 8, 2015, Pages 570-574

  Inchai, Juthamas ^a   Liwsrisakun, Chalerm ^a   Theerakittikul, Theerakorn ^a   Chaiwarith, Romanee ^a   Khositsakulchai, Weerayut ^b   Pothirat, Chaicharn ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b NAKORNPING HOSPITAL   (Thailand)

Author keywords

Acinetobacter baumannii; Extensively drug resistant; Multidrug resistant; Pandrug resistant; Risk factor; Ventilator associated pneumonia (VAP)

Indexed keywords

AMINOGLYCOSIDE; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; COLISTIN; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ADULT; AGE; ARTICLE; ARTIFICIAL VENTILATION; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; DIABETES MELLITUS; DISEASE SEVERITY; DRUG EXPOSURE; DRUG USE; FEMALE; GENDER; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION RISK; KIDNEY DISEASE; LENGTH OF STAY; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTIDRUG RESISTANCE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEPSIS; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SHOCK; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; THAILAND; VENTILATOR ASSOCIATED PNEUMONIA; ACINETOBACTER INFECTION; AGED; COMPLICATION; DISK DIFFUSION; DRUG EFFECTS; INTENSIVE CARE UNIT; MICROBIOLOGY; MIDDLE AGED; MULTIPLE ORGAN FAILURE; ORGAN DYSFUNCTION SCORE; RISK FACTOR; UNIVERSITY HOSPITAL; VERY ELDERLY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CARBAPENEMS; COLISTIN; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; ORGAN DYSFUNCTION SCORES; PNEUMONIA, VENTILATOR-ASSOCIATED; RETROSPECTIVE STUDIES; RISK FACTORS; THAILAND;

EID: 84937637863     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2015.04.010     Document Type: Article

References (24)

1. Ozgur E.S., Horasan E.S., Karaca K., Ersoz G., Nayci Atis S., Kaya A. Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii: risk factors, clinical features, and outcomes. Am J Infect Control 2014, 42:206-208.
2. Arvanitis M., Anagnostou T., Kourkoumpetis T.K., Ziakas P.D., Desalermos A., Mylonakis E. The impact of antimicrobial resistance and aging in VAP outcomes: experience from a large tertiary care center. PLoS One 2014, 9. e89984.
3. Fournier P.E., Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 2006, 42:692-699.
4. Chang H.C., Chen Y.C., Lin M.C., Liu S.F., Chung Y.H., Su M.C., et al. Mortality risk factors in patients with Acinetobacter baumannii ventilator: associated pneumonia. JFormos Med Assoc 2011, 110:564-571.
5. Depuydt P.O., Vandijck D.M., Bekaert M.A., Decruyenaere J.M., Blot S.I., Vogelaers D.P., et al. Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia. Crit care 2008, 12:R142.
6. Playford E.G., Craig J.C., Iredell J.R. Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences. JHosp Infect 2007, 65:204-211.
7. Chan M.C., Chiu S.K., Hsueh P.R., Wang N.C., Wang C.C., Fang C.T. Risk factors for healthcare-associated extensively drug-resistant Acinetobacter baumannii infections: a case-control study. PloS One 2014, 9. e85973.
8. Park Y.S., Lee H., Lee K.S., Hwang S.S., Cho Y.K., Kim H.Y., et al. Extensively drug-resistant Acinetobacter baumannii: risk factors for acquisition and prevalent OXA-type carbapenemases - a multicentre study. Int J Antimicrob Agents 2010, 36:430-435.
9. Souli M.G.I., Giamarellou H. Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Euro Surveill 2008, 13.
10. Maragakis L.L., Perl T.M. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008, 46:1254-1263.
11. Kuo S.C., Chang S.C., Wang H.Y., Lai J.F., Chen P.C., Shiau Y.R., et al. Emergence of extensively drug-resistant Acinetobacter baumannii complex over 10 years: nationwide data from the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program. BMC Infect Dis 2012, 28.
12. Bahador A., Taheri M., Pourakbari B., Hashemizadeh Z., Rostami H., Mansoori N., et al. Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants. Microb Drug Resist 2013, 19:397-406.
13. American Thoracic Society and Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416.
14. Magiorakos A.P., Srinivasan A., Carey R.B., Carmeli Y., Falagas M.E., Giske C.G., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012, 18:268-281.
15. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement 2014, 34. Clinical and Laboratory Standards Institute, Wayne, PA.
16. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock; 2012. Crit Care Med 2013, 41:580-637.
17. Chung D.R., Song J.H., Kim S.H., Thamlikitkul V., Huang S.G., Wang H., et al. High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia. Am J Respir Crit Care Med 2011, 184:1409-1417.
18. Ko K.S., Suh J.Y., Kwon K.T., Jung S.I., Park K.H., Kang C.I., et al. High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. JAntimicrob Chemother 2007, 60:1163-1167.
19. Chaiwarith R., Mahatthanaphak S., Boonchoo M., Supparatpinyo C., Sirisanthana T. Pandrug-resistant Acinetobacter baumannii at Maha-raj Nakorn Chiang Mai Hospital. JInfect Dis Antimicrob Agents 2005, 22:1-8.
20. Chittawatanarat K., Jaipakdee W., Chotirosniramit N., Chandacham K., Jirapongcharoenlap T. Microbiology, resistance patterns, and risk factors of mortality in ventilator-associated bacterial pneumonia in a Northern Thai tertiary-care university based general surgical intensive care unit. Infect Drug Resist 2014, 7:203-210.
21. Inchai J., Pothirat C., Bumroongkit C., Limsukon A., Khositsakulchai W., Liwsrisakun C. Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia. JIntensive Care 2015, 3:9. 10.1186/s40560-015-0077-4.
22. Jung J.Y., Park M.S., Kim S.E., Park B.H., Son J.Y., Kim E.Y., et al. Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit. BMC Infect Dis 2010, 10:228.
23. Matthaiou D.K., Michalopoulos A., Rafailidis P.I., Karageorgopoulos D.E., Papaioannou V., Ntani G., et al. Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study. Crit Care Med 2008, 36:807-811.
24. Baran G., Erbay A., Bodur H., Onguru P., Akinci E., Balaban N., et al. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections. Int J Infect Dis 2008, 12:16-21.